ClinicalTrials.gg
RecruitingNCT06407804Updated May 9, 2024

Effects of Thrower's Ten and Routine Physical Therapy in Patients With Shoulder Impingement Syndrome

An interventional study of Thrower's Ten Exercise Program and Routine physical therapy. in Shoulder Impingement Syndrome, sponsored by Riphah International University. Recruiting at 1 site in Pakistan. Open to participants aged 18 Years to 35 Years. Per ClinicalTrials.gov, last updated 2024-05-09.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years 1 month ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Feb 2024, registered May 2024).
  • Started Feb 2024; still recruiting 2 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 21 studies in Shoulder Impingement Syndrome with a site in Pakistan — 5 open to participants now, 7 under way, none of them phase 3. Shoulder Impingement Syndrome · Pakistan.

Planned enrollment
6th of 20
46 · median 35
Started
2024
with 3 others
No phase
20 of 21
5 open now
Registered
13th of 21
by date
Lead sponsor
7 of 21
Riphah International University

Among the 21 studies in Shoulder Impingement Syndrome with a site in Pakistan, this one is the 6th largest by planned enrollment of the 20 interventional ones that give a count, is one of 4 that started in 2024, is one of 20 with no phase, and was the 13th registered.

Shoulder Impingement Syndrome

321 studies on the registry are indexed under Shoulder Impingement Syndrome; 62 are open to participants now.

Browse Shoulder Impingement Syndrome studies →

Open to participants now

5 of the 21 studies in Shoulder Impingement Syndrome with a site in Pakistan are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 32 Shoulder Impingement Syndrome studies recruiting now, 3 (9%) set no upper age limit and 25 (78%) stop at 75 or younger; 1 takes children under 18; 6 take healthy volunteers.

This study: 18 Years to 35 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 21 studies in Shoulder Impingement Syndrome with a site in Pakistan, or all of them as a file.
02

Study summary

To compare the effects of thrower's ten and routine physical therapy on pain, range of motion and functional disability in patients with shoulder impingement syndrome

Read the detailed description

Shoulder impingement is a common cause of shoulder pain. It's also known as impingement syndrome or swimmer's shoulder, since it's common in swimmers. It occurs when there is impingement of tendons or bursa in the shoulder from bones of the shoulder. A randomized clinical trial will be conducted at Ibne Sina Hospital,Multan . Non probability convenience sampling technique will be applied on 46 patients who will be allocated through computerized randomization into group A \& group B to collect data. Group A will be given Throwers ten Program and group B will be given routine physical therapy along with baselines. The study will be completed within the time duration of nine months. Primary Outcome measures of the research will be pain, range of motion,function and disability . Data will be analyzed using SPSS software version 25. After assessing normality of data by Shapiro-wilk test, it will be decided either parametric or non-parametric test will be used within a group or between two groups.

03

Conditions studied

  • Shoulder Impingement Syndrome
04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age group 18-35 years
  • Male and female
  • Shoulder or neck pain within the prior 6month
  • 3 positive tests out of 5: Positive Neer's test, positive Hawkins test, positive Jobe's test, painful arc, and pain on resisted external rotation of the arm.

Exclusion criteria

Exclusion Criteria:

  • History of surgery of the affected shoulder
  • Fractures in around the shoulder
  • Neurological disorders leading to altered muscle activity
  • Systemic arthritic conditions (RA, Osteoporosis)
  • Disorders of the cervical spine
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
46 participants (estimated)

Study arms

  • Experimental
    Thrower's Ten Exercise Program

    1. D2 PNF flexion 2. D2 PNF extension 3. Internal rotation 4. External rotation 5. Push ups 6. Press ups

    Other: Thrower's Ten Exercise Program

  • Sham comparator
    Routine physical therapy

    1. Unilateral bench press 2. Bi lateral shoulder retraction 3. Extension in prone position 4. Neck retraction. Then isometrics will be performed which includes 1. Isometric shoulder internal and external rotation 2. Side lying shoulder external rotation 3. Scapular scaption exercise

    Other: Routine physical therapy.

Interventions

  • OtherThrower's Ten Exercise Program

    No Of Sessions Per Week: 3 Per Weeks for 6 weeks (50 Min per Session) No of repetitions; 2 sets for 10 repetitions with 1 minute rest between sets.

    Also known as: Routine physical therapy

  • OtherRoutine physical therapy.

    In this, the exercises will be performed in 2 sets and 10 repetitions with 5-10s hold and 30s to 1min rest between repetitions. No Of Sessions Per Week: 3 Per Weeks for 6 weeks (50 Min Per Session)

06

What researchers measure

Primary outcomes

  1. Numeric Pain Rating Scale

    The Numeric Pain Rating Scale (NPRS) is used to assess pain. On an 11-point Numeric scale, 0 represents the least amount of pain (no pain) and 10 Represents the most amount of pain (worst pain)

    Time frame: 6 weeks

  2. Range of Motion

    It is frequently employed as a benchmark technique for the assessment of Range of Motion (ROM) as the main component of all joint motions. The range of mobility of a joint is measured using a device known as a goniometer. Goniometry is the art and science of measuring the joint ranges in every plane of the joint. Short arm and long arm versions of the universal goniometer are available. Goniometric measurements are highly reliable provided measurements are conducted by the same therapist. Shoulder Abduction, Flexion and External rotation range will be taken by a Universal Goniometer.

    Time frame: 6 weeks

  3. Shoulder pain and disability index (SPADI)

    The SPADI (Shoulder Pain and impairment Index) was created to assess current shoulder pain and impairment in an outpatient environment. The SPADI consists of 13 items that assess two domains: a 5-item subscale for pain and an 8-item subscale for disability. The SPADI has since been used in both primary care on mixed diagnosis and surgical patient populations including rotator cuff disease, osteoarthritis, and rheumatoid arthritis, adhesive capsulitis ,joint replacement surgery , and in a large population-based study of shoulder symptoms

    Time frame: 6 weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2024 (actual). Primary completion is estimated for Oct 2024, 8 months after the start.

Of 171 non-industry interventional studies with no phase under Shoulder Impingement Syndrome, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 24. This study's planned 8 months is below that.

Counting every sponsor, half of 173 studies reached it within 12 months; a quarter within 5 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2024
First posted
May 9, 2024
StartActual
Feb 1, 2024
Primary completionEst.
Oct 10, 2024
CompletionEst.
Nov 10, 2024
Last update
May 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06407804
Responsible party
Sponsor
First posted
May 9, 2024
Start date
Feb 1, 2024
Primary completion
Oct 10, 2024 (estimated)
Completion
Nov 10, 2024 (estimated)
Last update
May 9, 2024

Study contacts

Zoya Shafqat, MS-DPT
Contact
Zoyabatool100@gmail.com
0336 0670767
Rabiya Noor, PHD
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion